Search

everythinglearnresearchcommunity

for

Search:↓

Blood type affects COVID-19 infection rates differently in Europe and Africa.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Alopecia indicates more severe resistance to 1,25-dihydroxyvitamin D.

Child with rickets improved with a specific vitamin D therapy, but alopecia did not change.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Keratin 19 helps identify skin stem cells, with its presence varying by body location, age, and culture stage.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

COVID-19 affects multiple body systems, not just the lungs.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.

Pregnant and breastfeeding women should get COVID-19 vaccines for safety and protection.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 can cause skin changes, possibly from the virus, drugs, or lifestyle changes.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

MMP-19 may worsen skin diseases by affecting skin growth and inflammation.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

COVID-19 vaccination may trigger lupus in some people.

Scientists discovered a unique hair protein, KAP24.1, with a special structure, found only in the upper part of hair cuticles.